Tenon Medical (TNON) Liabilities and Shareholders Equity (2021 - 2026)

Tenon Medical's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 4.15% year-over-year to $12.8 million in Q1 2026; TTM through Mar 2026 was $45.1 million, a 6.61% increase from a year earlier, with the FY2025 full-year figure at $10.8 million, up 9.32% from the prior year.
• Liabilities and Shareholders Equity climbed to $12.8 million in Q1 2026 per TNON's latest filing, from $10.8 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $18.1 million in Q2 2022 and bottomed at $6.0 million in Q2 2024.
• The 5-year median for Liabilities and Shareholders Equity is $10.4 million (2025), against an average of $10.5 million.
• Across the five-year window, Liabilities and Shareholders Equity plunged 51.01% in 2023 and jumped 85.05% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $11.1 million in 2022, then sank by 42.78% to $6.3 million in 2023, then jumped by 55.13% to $9.8 million in 2024, then climbed by 9.32% to $10.8 million in 2025, then increased by 19.31% to $12.8 million in 2026.
• Per Business Quant, the three latest TNON Liabilities and Shareholders Equity figures stand at $12.8 million (Q1 2026), $10.8 million (Q4 2025), and $10.4 million (Q3 2025).